PARP1 and cervical carcinoma: Additionally, we observed that the treatment with PTX + CIS increased PARP-1 cleavage in SiHaP and SiHaCIS-R cells, which potentiates the apoptotic effects of these drugs, due to that these mechanisms are involved in the induction of apoptosis in human cervical cancer cells (34).